Details
Stereochemistry | ACHIRAL |
Molecular Formula | C22H30N2O2S |
Molecular Weight | 386.551 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC(=O)N(C1=CC=CC=C1)C2(COC)CCN(CCC3=CC=CS3)CC2
InChI
InChIKey=GGCSSNBKKAUURC-UHFFFAOYSA-N
InChI=1S/C22H30N2O2S/c1-3-21(25)24(19-8-5-4-6-9-19)22(18-26-2)12-15-23(16-13-22)14-11-20-10-7-17-27-20/h4-10,17H,3,11-16,18H2,1-2H3
Molecular Formula | C22H30N2O2S |
Molecular Weight | 386.551 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:17:11 UTC 2023
by
admin
on
Fri Dec 15 15:17:11 UTC 2023
|
Record UNII |
AFE2YW0IIZ
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
DEA NO. |
9740
Created by
admin on Fri Dec 15 15:17:11 UTC 2023 , Edited by admin on Fri Dec 15 15:17:11 UTC 2023
|
||
|
NCI_THESAURUS |
C67413
Created by
admin on Fri Dec 15 15:17:11 UTC 2023 , Edited by admin on Fri Dec 15 15:17:11 UTC 2023
|
||
|
WHO-VATC |
QN01AH03
Created by
admin on Fri Dec 15 15:17:11 UTC 2023 , Edited by admin on Fri Dec 15 15:17:11 UTC 2023
|
||
|
LIVERTOX |
904
Created by
admin on Fri Dec 15 15:17:11 UTC 2023 , Edited by admin on Fri Dec 15 15:17:11 UTC 2023
|
||
|
WIKIPEDIA |
List_of_fentanyl_analogues
Created by
admin on Fri Dec 15 15:17:11 UTC 2023 , Edited by admin on Fri Dec 15 15:17:11 UTC 2023
|
||
|
WHO-ATC |
N01AH03
Created by
admin on Fri Dec 15 15:17:11 UTC 2023 , Edited by admin on Fri Dec 15 15:17:11 UTC 2023
|
||
|
NDF-RT |
N0000175684
Created by
admin on Fri Dec 15 15:17:11 UTC 2023 , Edited by admin on Fri Dec 15 15:17:11 UTC 2023
|
||
|
NDF-RT |
N0000175690
Created by
admin on Fri Dec 15 15:17:11 UTC 2023 , Edited by admin on Fri Dec 15 15:17:11 UTC 2023
|
||
|
NCI_THESAURUS |
C1506
Created by
admin on Fri Dec 15 15:17:11 UTC 2023 , Edited by admin on Fri Dec 15 15:17:11 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
9316
Created by
admin on Fri Dec 15 15:17:11 UTC 2023 , Edited by admin on Fri Dec 15 15:17:11 UTC 2023
|
PRIMARY | |||
|
6760
Created by
admin on Fri Dec 15 15:17:11 UTC 2023 , Edited by admin on Fri Dec 15 15:17:11 UTC 2023
|
PRIMARY | |||
|
3534
Created by
admin on Fri Dec 15 15:17:11 UTC 2023 , Edited by admin on Fri Dec 15 15:17:11 UTC 2023
|
PRIMARY | |||
|
56795
Created by
admin on Fri Dec 15 15:17:11 UTC 2023 , Edited by admin on Fri Dec 15 15:17:11 UTC 2023
|
PRIMARY | RxNorm | ||
|
SUFENTANIL
Created by
admin on Fri Dec 15 15:17:11 UTC 2023 , Edited by admin on Fri Dec 15 15:17:11 UTC 2023
|
PRIMARY | |||
|
100000089189
Created by
admin on Fri Dec 15 15:17:11 UTC 2023 , Edited by admin on Fri Dec 15 15:17:11 UTC 2023
|
PRIMARY | |||
|
41693
Created by
admin on Fri Dec 15 15:17:11 UTC 2023 , Edited by admin on Fri Dec 15 15:17:11 UTC 2023
|
PRIMARY | |||
|
56030-54-7
Created by
admin on Fri Dec 15 15:17:11 UTC 2023 , Edited by admin on Fri Dec 15 15:17:11 UTC 2023
|
PRIMARY | |||
|
C61956
Created by
admin on Fri Dec 15 15:17:11 UTC 2023 , Edited by admin on Fri Dec 15 15:17:11 UTC 2023
|
PRIMARY | |||
|
m10288
Created by
admin on Fri Dec 15 15:17:11 UTC 2023 , Edited by admin on Fri Dec 15 15:17:11 UTC 2023
|
PRIMARY | Merck Index | ||
|
4048
Created by
admin on Fri Dec 15 15:17:11 UTC 2023 , Edited by admin on Fri Dec 15 15:17:11 UTC 2023
|
PRIMARY | |||
|
Sufentanil
Created by
admin on Fri Dec 15 15:17:11 UTC 2023 , Edited by admin on Fri Dec 15 15:17:11 UTC 2023
|
PRIMARY | |||
|
D017409
Created by
admin on Fri Dec 15 15:17:11 UTC 2023 , Edited by admin on Fri Dec 15 15:17:11 UTC 2023
|
PRIMARY | |||
|
2491
Created by
admin on Fri Dec 15 15:17:11 UTC 2023 , Edited by admin on Fri Dec 15 15:17:11 UTC 2023
|
PRIMARY | |||
|
DTXSID6023604
Created by
admin on Fri Dec 15 15:17:11 UTC 2023 , Edited by admin on Fri Dec 15 15:17:11 UTC 2023
|
PRIMARY | |||
|
CHEMBL658
Created by
admin on Fri Dec 15 15:17:11 UTC 2023 , Edited by admin on Fri Dec 15 15:17:11 UTC 2023
|
PRIMARY | |||
|
SUB10671MIG
Created by
admin on Fri Dec 15 15:17:11 UTC 2023 , Edited by admin on Fri Dec 15 15:17:11 UTC 2023
|
PRIMARY | |||
|
AFE2YW0IIZ
Created by
admin on Fri Dec 15 15:17:11 UTC 2023 , Edited by admin on Fri Dec 15 15:17:11 UTC 2023
|
PRIMARY | |||
|
SUFENTANIL
Created by
admin on Fri Dec 15 15:17:11 UTC 2023 , Edited by admin on Fri Dec 15 15:17:11 UTC 2023
|
PRIMARY | Sufentanil first was synthesized at Janssen Pharmaceutica in 1974. Sufentanil is marketed for use by specialist centers under different trade names, such as Sufenta and Sufentil. Sufentanil with and without lidocaine or mepivacaine is available as a transdermal patch similar to Duragesic in Europe under trade names such as Chronogesic. | ||
|
DB00708
Created by
admin on Fri Dec 15 15:17:11 UTC 2023 , Edited by admin on Fri Dec 15 15:17:11 UTC 2023
|
PRIMARY | |||
|
AFE2YW0IIZ
Created by
admin on Fri Dec 15 15:17:11 UTC 2023 , Edited by admin on Fri Dec 15 15:17:11 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> AGONIST |
10 times more potent than Fentanyl.
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
APPROXIMATE PURE ANHYDROUS DRUG CONTENT (IN PERCENT)
|
||
|
BINDER->LIGAND |
BINDING
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE INACTIVE -> PARENT |
LIVER MICROSOMES
MAJOR
|
||
|
METABOLITE -> PARENT |
|
||
|
METABOLITE INACTIVE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
|
|||